Esophageal cancer (EC) is a prevalent malignant tumor that affects the digestive system and is often linked to a poor prognosis. The absence of effective early screening methods results in the diagnosis of esophageal ...Esophageal cancer (EC) is a prevalent malignant tumor that affects the digestive system and is often linked to a poor prognosis. The absence of effective early screening methods results in the diagnosis of esophageal cancer (EC) patients at advanced or metastatic stages. While historically considered incurable, ongoing advancements in medical research have led to the integration of various treatment modalities as primary approaches for managing advanced endometrial cancer. These modalities include surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy. Notably, the introduction of targeted therapy and immunotherapy has significantly enhanced the survival rates of individuals with EC. Immunotherapy has appeared as the predominant treatment for advanced esophageal cancer, while targeted therapy faces certain obstacles. Consequently, this review primarily focuses on the advancements in targeted therapy for esophageal cancer (EC), evaluating the effectiveness and safety of relevant medications, and aiming to provide guidance for the comprehensive management of EC based on current research findings.展开更多
Fibroblast activation protein(Fap)is a serine protease that degrades denatured type I collagen,α2-antiplasmin and FGF21.Fap is highly expressed in bone marrow stromal cells and functions as an osteogenic suppressor a...Fibroblast activation protein(Fap)is a serine protease that degrades denatured type I collagen,α2-antiplasmin and FGF21.Fap is highly expressed in bone marrow stromal cells and functions as an osteogenic suppressor and can be inhibited by the bone growth factor Osteolectin(Oln).Fap is also expressed in synovial fibroblasts and positively correlated with the severity of rheumatoid arthritis(RA).However,whether Fap plays a critical role in osteoarthritis(OA)remains poorly understood.Here,we found that Fap is significantly elevated in osteoarthritic synovium,while the genetic deletion or pharmacological inhibition of Fap significantly ameliorated posttraumatic OA in mice.Mechanistically,we found that Fap degrades denatured type II collagen(Col II)and Mmp13-cleaved native Col II.Intra-articular injection of r Fap significantly accelerated Col II degradation and OA progression.In contrast,Oln is expressed in the superficial layer of articular cartilage and is significantly downregulated in OA.Genetic deletion of Oln significantly exacerbated OA progression,which was partially rescued by Fap deletion or inhibition.Intra-articular injection of r Oln significantly ameliorated OA progression.Taken together,these findings identify Fap as a critical pathogenic factor in OA that could be targeted by both synthetic and endogenous inhibitors to ameliorate articular cartilage degradation.展开更多
Small cell lung cancer is an invasive neuroendocrine carcinoma with early metastasis potential. It tends to grow rapidly and metastasize early, with the majority of patients diagnosed as advanced stage small cell lung...Small cell lung cancer is an invasive neuroendocrine carcinoma with early metastasis potential. It tends to grow rapidly and metastasize early, with the majority of patients diagnosed as advanced stage small cell lung cancer (ES-SCLC). Systemic treatment consisting of platinum drugs and etoposide chemotherapy is the main treatment method, although the objective effective rate of this combination is 60% - 80%. However, most SCLC patients experience disease progression shortly after initial treatment, with a median overall survival of 10 months. There are few second-line treatment drugs available, and immunotherapy using checkpoint inhibitors has completely changed the treatment of many cancer types. Adding immune checkpoint inhibitors (ICI) to conventional chemotherapy as first-line treatment can improve the survival rate of widespread small cell lung cancer (ES-SCLC), but so far, there are no definitive factors to determine patients who are more likely to benefit from immunotherapy. This review summarizes the results of immunotherapy trials for small cell lung cancer. And a review was conducted on the predictive factors of these trials, with special emphasis on the expression of PD-L1 in small cell lung cancer to determine its clinical value.展开更多
The exon numbers and lengths vary in different eukaryotic species. With increasing completed genomic sequences, it is indispensable to reanalyze the gene organization in diverse eukaryotic genomes. We performed a larg...The exon numbers and lengths vary in different eukaryotic species. With increasing completed genomic sequences, it is indispensable to reanalyze the gene organization in diverse eukaryotic genomes. We performed a large-scale comparative analysis of the exon-intron structure in 72 eukaryotic organisms, including plants, fungi and animals. We confirmed that the exon-intron structure varies massively among eukaryotic genomes and revealed some lineage-specific features of eukaryotic genes. These include a teleost-specific exon-intron structure pattern, relatively small introns and large exons in fungi and algae, and a gradual expansion of introns in vertebrates. Furthermore, the conservation analysis of exon-intron boundaries indicates that several bases near splice site junctions are different in introns with variable length among different species. After comparison, we identified a trend showing increases in intron densities and lengths in diverse species from fungi, plants, invertebrates to vertebrates, while it was the opposite in relation to exon lengths. The statistical properties of eukaryotic genomic organization suggest that genome-specific features are preserved by diverse evolutionary processes, which paves way for further research on the diversification of eukaryotic evolution.展开更多
In this study,a high-efficiency cationic flocculant,P(DAC-MAPTAC-AM),was successfully prepared using UV-induced polymerization technology.The monomer Acrylamide(AM):Acryloxyethyl Trimethyl ammonium chloride(DAC):metha...In this study,a high-efficiency cationic flocculant,P(DAC-MAPTAC-AM),was successfully prepared using UV-induced polymerization technology.The monomer Acrylamide(AM):Acryloxyethyl Trimethyl ammonium chloride(DAC):methacrylamido propyl trimethyl ammonium chloride(MAPTAC)ratio,monomer concentration,photoinitiator concentration,urea content,and cationic monomer DAC:MAPTAC ratio,light time,and power of highpressure mercury lamp were studied.The characteristic groups,characteristic diffraction peaks,and characteristic proton peaks of P(DAC-MAPTAC-AM)were confirmed by fourier transform infrared spectroscopy(FTIR),X-Ray diffraction(XRD),1H nuclear magnetic resonance spectrometer(1H NMR),and scanning electron microscopy(SEM).The effects of dosage,pH value,and velocity gradient(G)value on the removal efficiencies of turbidity,COD,ammonia nitrogen,and total phenol by poly aluminum ferric chloride(PAFC),P(DACMAPTAC-AM),and PAFC/P(DAC-MAPTAC-AM)in the flocculation treatment of coal chemical wastewater were investigated.Results showed that the optimal conditions for the flocculation of coal chemical wastewater using P(DAC-MAPTAC-AM)alone are as follows:dosage of 8-12 mg/L,G value of 100-250 s^-1,and pH value of 4-8.The optimal dosage of PAFC is 90-150 mg/L with a pH of 2-12.The optimal dosage for PAFC/P(DAC-MAPTAC-AM)is as follows:PAFC dosage of 90-150 mg/L,P(DAC-MAPTAC-AM)dosage of 8-12 mg/L,and pH range of 2-6.When P(DAC-MAPTAC-AM)was used alone,the optimal removal efficiencies of turbidity,COD,ammonia nitrogen,and total phenol were 81.0%,35.0%,75.0%,and 80.3%,respectively.PAFC has good tolerance to wastewater pH and good pH buffering.Thus,the flocculation treatment of coal chemical wastewater using the PAFC/P(DAC-MAPTAC-AM)compound also exhibits excellent resistance and buffering capacity.展开更多
文摘Esophageal cancer (EC) is a prevalent malignant tumor that affects the digestive system and is often linked to a poor prognosis. The absence of effective early screening methods results in the diagnosis of esophageal cancer (EC) patients at advanced or metastatic stages. While historically considered incurable, ongoing advancements in medical research have led to the integration of various treatment modalities as primary approaches for managing advanced endometrial cancer. These modalities include surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy. Notably, the introduction of targeted therapy and immunotherapy has significantly enhanced the survival rates of individuals with EC. Immunotherapy has appeared as the predominant treatment for advanced esophageal cancer, while targeted therapy faces certain obstacles. Consequently, this review primarily focuses on the advancements in targeted therapy for esophageal cancer (EC), evaluating the effectiveness and safety of relevant medications, and aiming to provide guidance for the comprehensive management of EC based on current research findings.
基金National Key R&D Program of China(2022YFA1103200,2017YFA0106400,2021YFA1100900)Ministry of Science and Technology of China(2020YFC2002804)+3 种基金National Natural Science Foundation of China(91749124,81772389,82070108)Major Program of Development Fund for Shanghai Zhangjiang National Innovation Demonstration Zone(ZJ2018-ZD-004)Fundamental Research Funds for the Central Universities(22120190149 and kx0200020173386)Peak Disciplines(Type IV)of Institutions of Higher Learning in Shanghai。
文摘Fibroblast activation protein(Fap)is a serine protease that degrades denatured type I collagen,α2-antiplasmin and FGF21.Fap is highly expressed in bone marrow stromal cells and functions as an osteogenic suppressor and can be inhibited by the bone growth factor Osteolectin(Oln).Fap is also expressed in synovial fibroblasts and positively correlated with the severity of rheumatoid arthritis(RA).However,whether Fap plays a critical role in osteoarthritis(OA)remains poorly understood.Here,we found that Fap is significantly elevated in osteoarthritic synovium,while the genetic deletion or pharmacological inhibition of Fap significantly ameliorated posttraumatic OA in mice.Mechanistically,we found that Fap degrades denatured type II collagen(Col II)and Mmp13-cleaved native Col II.Intra-articular injection of r Fap significantly accelerated Col II degradation and OA progression.In contrast,Oln is expressed in the superficial layer of articular cartilage and is significantly downregulated in OA.Genetic deletion of Oln significantly exacerbated OA progression,which was partially rescued by Fap deletion or inhibition.Intra-articular injection of r Oln significantly ameliorated OA progression.Taken together,these findings identify Fap as a critical pathogenic factor in OA that could be targeted by both synthetic and endogenous inhibitors to ameliorate articular cartilage degradation.
文摘Small cell lung cancer is an invasive neuroendocrine carcinoma with early metastasis potential. It tends to grow rapidly and metastasize early, with the majority of patients diagnosed as advanced stage small cell lung cancer (ES-SCLC). Systemic treatment consisting of platinum drugs and etoposide chemotherapy is the main treatment method, although the objective effective rate of this combination is 60% - 80%. However, most SCLC patients experience disease progression shortly after initial treatment, with a median overall survival of 10 months. There are few second-line treatment drugs available, and immunotherapy using checkpoint inhibitors has completely changed the treatment of many cancer types. Adding immune checkpoint inhibitors (ICI) to conventional chemotherapy as first-line treatment can improve the survival rate of widespread small cell lung cancer (ES-SCLC), but so far, there are no definitive factors to determine patients who are more likely to benefit from immunotherapy. This review summarizes the results of immunotherapy trials for small cell lung cancer. And a review was conducted on the predictive factors of these trials, with special emphasis on the expression of PD-L1 in small cell lung cancer to determine its clinical value.
文摘The exon numbers and lengths vary in different eukaryotic species. With increasing completed genomic sequences, it is indispensable to reanalyze the gene organization in diverse eukaryotic genomes. We performed a large-scale comparative analysis of the exon-intron structure in 72 eukaryotic organisms, including plants, fungi and animals. We confirmed that the exon-intron structure varies massively among eukaryotic genomes and revealed some lineage-specific features of eukaryotic genes. These include a teleost-specific exon-intron structure pattern, relatively small introns and large exons in fungi and algae, and a gradual expansion of introns in vertebrates. Furthermore, the conservation analysis of exon-intron boundaries indicates that several bases near splice site junctions are different in introns with variable length among different species. After comparison, we identified a trend showing increases in intron densities and lengths in diverse species from fungi, plants, invertebrates to vertebrates, while it was the opposite in relation to exon lengths. The statistical properties of eukaryotic genomic organization suggest that genome-specific features are preserved by diverse evolutionary processes, which paves way for further research on the diversification of eukaryotic evolution.
基金National Key Research and Development Program of China(No.2017YFB0602500)2018 Six Talent Peaks Project of Jiangsu Province(No.JNHB-038)。
文摘In this study,a high-efficiency cationic flocculant,P(DAC-MAPTAC-AM),was successfully prepared using UV-induced polymerization technology.The monomer Acrylamide(AM):Acryloxyethyl Trimethyl ammonium chloride(DAC):methacrylamido propyl trimethyl ammonium chloride(MAPTAC)ratio,monomer concentration,photoinitiator concentration,urea content,and cationic monomer DAC:MAPTAC ratio,light time,and power of highpressure mercury lamp were studied.The characteristic groups,characteristic diffraction peaks,and characteristic proton peaks of P(DAC-MAPTAC-AM)were confirmed by fourier transform infrared spectroscopy(FTIR),X-Ray diffraction(XRD),1H nuclear magnetic resonance spectrometer(1H NMR),and scanning electron microscopy(SEM).The effects of dosage,pH value,and velocity gradient(G)value on the removal efficiencies of turbidity,COD,ammonia nitrogen,and total phenol by poly aluminum ferric chloride(PAFC),P(DACMAPTAC-AM),and PAFC/P(DAC-MAPTAC-AM)in the flocculation treatment of coal chemical wastewater were investigated.Results showed that the optimal conditions for the flocculation of coal chemical wastewater using P(DAC-MAPTAC-AM)alone are as follows:dosage of 8-12 mg/L,G value of 100-250 s^-1,and pH value of 4-8.The optimal dosage of PAFC is 90-150 mg/L with a pH of 2-12.The optimal dosage for PAFC/P(DAC-MAPTAC-AM)is as follows:PAFC dosage of 90-150 mg/L,P(DAC-MAPTAC-AM)dosage of 8-12 mg/L,and pH range of 2-6.When P(DAC-MAPTAC-AM)was used alone,the optimal removal efficiencies of turbidity,COD,ammonia nitrogen,and total phenol were 81.0%,35.0%,75.0%,and 80.3%,respectively.PAFC has good tolerance to wastewater pH and good pH buffering.Thus,the flocculation treatment of coal chemical wastewater using the PAFC/P(DAC-MAPTAC-AM)compound also exhibits excellent resistance and buffering capacity.